MINNEAPOLIS, Minnesota -- Medtronic, Inc. today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback